These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 3546806)

  • 1. [Metabolic bone diseases: glucocorticoid-induced osteopenia].
    Yamada H; Suzuki Y; Ichikawa Y; Homma M
    Nihon Rinsho; 1986 Nov; 44(11):2507-16. PubMed ID: 3546806
    [No Abstract]   [Full Text] [Related]  

  • 2. [Glucocorticoid-induced osteopenia].
    Glerup H; Eriksen EF; Mosekilde L
    Ugeskr Laeger; 1994 Sep; 156(38):5489-94. PubMed ID: 7941080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mineralocorticoid receptor function in bone metabolism and its role in glucocorticoid-induced osteopenia.
    Fumoto T; Ishii KA; Ito M; Berger S; Schütz G; Ikeda K
    Biochem Biophys Res Commun; 2014 May; 447(3):407-12. PubMed ID: 24713303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metabolic bone diseases: various factors influencing bone resorption and osteogenesis--with special reference to the mechanism of action--steroid hormone].
    Morimoto Y
    Nihon Rinsho; 1986 Nov; 44(11):2391-8. PubMed ID: 3546790
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of oral calcium and vitamin D on glucocorticoid-induced osteopenia.
    Bijlsma JW; Raymakers JA; Mosch C; Hoekstra A; Derksen RH; Baart de la Faille H; Duursma SA
    Clin Exp Rheumatol; 1988; 6(2):113-9. PubMed ID: 3180536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new vitamin D analog, 2MD, restores trabecular and cortical bone mass and strength in ovariectomized rats with established osteopenia.
    Ke HZ; Qi H; Crawford DT; Simmons HA; Xu G; Li M; Plum L; Clagett-Dame M; DeLuca HF; Thompson DD; Brown TA
    J Bone Miner Res; 2005 Oct; 20(10):1742-55. PubMed ID: 16160732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comment on the article "Characteristics of patients with osteopenia treated with glucocorticoids at the Osteoporosis Clinic of the Medical Faculty Hospital in Hradec Kralove"].
    Horák P
    Vnitr Lek; 2003 Jan; 49(1):10-1. PubMed ID: 12666422
    [No Abstract]   [Full Text] [Related]  

  • 8. Growth hormone increases cortical and cancellous bone mass in young growing rats with glucocorticoid-induced osteopenia.
    Ortoft G; Andreassen TT; Oxlund H
    J Bone Miner Res; 1999 May; 14(5):710-21. PubMed ID: 10320519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical studies on glucocorticoid-induced osteoporosis].
    Tanaka I; Oshima H
    Nihon Rinsho Meneki Gakkai Kaishi; 2001 Aug; 24(4):142-151. PubMed ID: 16646164
    [No Abstract]   [Full Text] [Related]  

  • 10. [Characteristics of patients with osteopenia treated with glucocorticoids at the Osteoporosis Clinic of the Medical Faculty Hospital in Hradec Kralove].
    Müllerová H; Prixová M; Vlcek J; Mokrosová K; Rehorková P; Palicka V
    Vnitr Lek; 2003 Jan; 49(1):32-6. PubMed ID: 12666431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary hyperparathyroidism in primary osteoporosis and osteopenia: optimizing calcium and vitamin D intakes to levels recommended by expert panels may not be sufficient for correction.
    Yendt ER; Kovacs KA; Jones G
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):855-63. PubMed ID: 18419790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitonin: chronotherapeutic effect on osteopenia in the ovariectomized rat.
    Simmons DJ; Yang C; Gundberg CM; Kidder L; Cornelissen G; Thomas M; Lozano R; Sandstead E
    Prog Clin Biol Res; 1990; 341A():517-27. PubMed ID: 2217271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dietary NaCl supplementation on bone synthesis of hydroxyproline, urinary hydroxyproline excretion and bone 45Ca uptake in the rat.
    Goulding A; Gold E
    Horm Metab Res; 1988 Dec; 20(12):743-5. PubMed ID: 3220450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventive effects of berberine on glucocorticoid-induced osteoporosis in rats.
    Xu D; Yang W; Zhou C; Liu Y; Xu B
    Planta Med; 2010 Nov; 76(16):1809-13. PubMed ID: 20577944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Glucocorticoid-induced osteoporosis--epidemiology and pathogenesis].
    Suzuki Y
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():668-72. PubMed ID: 15035206
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of cyclosporin A on bone mineral metabolism in experimental diabetes mellitus in the rat.
    Epstein S; Takizawa M; Stein B; Katz IA; Joffe II; Romero DF; Liang XG; Li M; Ke HZ; Jee WS
    J Bone Miner Res; 1994 Apr; 9(4):557-66. PubMed ID: 8030444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prednisone-induced osteopenia in beagles: variable effects mediated by differential suppression of bone formation.
    Quarles LD
    Am J Physiol; 1992 Jul; 263(1 Pt 1):E136-41. PubMed ID: 1636691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histomorphometric analysis of glucocorticoid-induced osteoporosis.
    Dalle Carbonare L; Bertoldo F; Valenti MT; Zenari S; Zanatta M; Sella S; Giannini S; Cascio VL
    Micron; 2005; 36(7-8):645-52. PubMed ID: 16243531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoid osteopenia.
    Kaplan FS
    Orthop Nurs; 1985; 4(3):35-8. PubMed ID: 3847860
    [No Abstract]   [Full Text] [Related]  

  • 20. Intact parathyroid hormone levels are not elevated in glucocorticoid-treated subjects.
    Paz-Pacheco E; Fuleihan GE; LeBoff MS
    J Bone Miner Res; 1995 Nov; 10(11):1713-8. PubMed ID: 8592948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.